ask="0.60"
ask_size="3500"
average_daily_volume="527043"
bid="N/A"
bid_size="N/A"
book_value="0.81"
change="-0.01"
change_from_200_day_moving_average="0.00"
change_from_50_day_moving_average="-0.05"
change_from_52_week_high="-0.91"
change_From_52_week_low="0.18"
change_in_percent="-1.94%"
close="0.51"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.54"
ebitda="-17.93M"
eps_estimate_current_year="-0.78"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.57"
ex_dividend_date="N/A"
float_shares="29628000"
high="0.53"
high_52_weeks="1.42"
last_trade_date="3/8/2017"
last_trade_price="0.51"
last_trade_size="100"
last_trade_time="3:16pm"
low="0.50"
low_52_weeks="0.33"
market_capitalization="15.31M"
moving_average_200_day="0.51"
moving_average_50_day="0.56"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.90"
open="0.53"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.63%"
percent_change_from_50_day_moving_average="-9.71%"
percent_change_from_52_week_high="-64.08%"
percent_change_from_52_week_low="+54.08%"
previous_close="0.52"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.64"
price_per_sales="1.41"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="4.06"
stock_exchange="NCM"
symbol="OGXI"
volume="48636"
weeks_range_52="0.33 - 1.42"
